This report looks at how the industry has shifted its approach to how clinical trials are managed and as a result, made the industry more patient-centric.
Category Archives: Achieving Regulatory Compliance
PRISYM ID to attend Clinical Trial Supply Europe 2022
PRISYM ID to attend IQPC’s Clinical Trial Supply 2022
PRISYM ID to attend Clinical Trial Supply New England 2022
Has COVID-19 Revolutionized the Clinical Trials Supply Chain?
Why Medical Device Manufacturers Must Look at the Bigger Picture When Implementing a GLS
Clinical Trials: Managing Labeling Approvals with Multi-Language and Multi-Region Regulations
Now more than ever, the clinical trials’ landscape touches more regions than ever before. As a result, new studies are grappling with the challenge of managing variable local language labeling requirements.
